AU6502199A - Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer - Google Patents
Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancerInfo
- Publication number
- AU6502199A AU6502199A AU65021/99A AU6502199A AU6502199A AU 6502199 A AU6502199 A AU 6502199A AU 65021/99 A AU65021/99 A AU 65021/99A AU 6502199 A AU6502199 A AU 6502199A AU 6502199 A AU6502199 A AU 6502199A
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- treatment
- nucleic acids
- prostate cancer
- expression analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16415998A | 1998-09-30 | 1998-09-30 | |
US09164159 | 1998-09-30 | ||
US09/163,759 US6872811B1 (en) | 1998-09-30 | 1998-09-30 | HRPCa9 and HRPCa10 nucleic acids and polypeptides |
US09163759 | 1998-09-30 | ||
PCT/US1999/022535 WO2000018961A2 (en) | 1998-09-30 | 1999-09-30 | Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6502199A true AU6502199A (en) | 2000-04-17 |
Family
ID=26859918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU65021/99A Abandoned AU6502199A (en) | 1998-09-30 | 1999-09-30 | Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1117836A2 (en) |
JP (1) | JP2002531061A (en) |
AU (1) | AU6502199A (en) |
CA (1) | CA2344550A1 (en) |
WO (1) | WO2000018961A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7037667B1 (en) | 1998-06-01 | 2006-05-02 | Agensys, Inc. | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
PT1109937E (en) * | 1998-09-02 | 2009-02-10 | Diadexus Inc | Method of diagnosing, monitoring, staging, and imaging various cancers |
US6902892B1 (en) | 1998-10-19 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
US6355430B1 (en) | 1998-12-24 | 2002-03-12 | Millennium Pharmaceuticals, Inc. | Diagnostic and screening methods employing KIAA0101 |
WO2000065067A2 (en) * | 1999-04-23 | 2000-11-02 | University Of Washington | Prostate-specific polynucleotides, polypeptides and their methods of use |
CA2415923C (en) * | 2000-07-12 | 2011-10-25 | Agensys, Inc. | Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
US6821731B2 (en) | 2000-11-28 | 2004-11-23 | Wyeth | Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer |
EP1343912A2 (en) | 2000-11-28 | 2003-09-17 | Wyeth | Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
US9957569B2 (en) | 2005-09-12 | 2018-05-01 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
AU2006291054B2 (en) | 2005-09-12 | 2011-10-13 | The Brigham And Women's Hospital, Inc. | Recurrent gene fusions in prostate cancer |
AU2008275303B2 (en) | 2007-07-06 | 2012-05-03 | The Regents Of The University Of Michigan | MIPOL1-ETV1 gene rearrangements |
WO2009020521A2 (en) | 2007-08-03 | 2009-02-12 | The Brigham And Women's Hospital, Inc. | Identification and treatment of estrogen responsive prostate tumors |
CA2774349C (en) | 2009-09-17 | 2019-03-19 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
US8945556B2 (en) | 2010-11-19 | 2015-02-03 | The Regents Of The University Of Michigan | RAF gene fusions |
JP2012196211A (en) * | 2012-04-10 | 2012-10-18 | Japan Science & Technology Agency | Prostatic cancer marker polypeptide, antibody to the same, and method for diagnosing prostatic cancer using the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995028498A1 (en) * | 1994-04-15 | 1995-10-26 | The Trustees Of Columbia University In The City Of New York | Method for molecular staging of prostate cancer |
US5786362A (en) * | 1994-06-16 | 1998-07-28 | University Of Miami | Method of treating Hormone independent cancer |
WO1997027317A1 (en) * | 1996-01-23 | 1997-07-31 | Affymetrix, Inc. | Nucleic acid analysis techniques |
WO1998004689A1 (en) * | 1995-07-31 | 1998-02-05 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
US5861248A (en) * | 1996-03-29 | 1999-01-19 | Urocor, Inc. | Biomarkers for detection of prostate cancer |
US5783435A (en) * | 1996-08-06 | 1998-07-21 | Lamparski; Henry G. | Prostate cancer drug screenings |
AU6451798A (en) * | 1997-03-07 | 1998-09-22 | Reprogen, Inc. | Prostate cancer-specific marker |
-
1999
- 1999-09-30 JP JP2000572408A patent/JP2002531061A/en active Pending
- 1999-09-30 WO PCT/US1999/022535 patent/WO2000018961A2/en not_active Application Discontinuation
- 1999-09-30 EP EP99952976A patent/EP1117836A2/en not_active Withdrawn
- 1999-09-30 AU AU65021/99A patent/AU6502199A/en not_active Abandoned
- 1999-09-30 CA CA002344550A patent/CA2344550A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000018961A3 (en) | 2001-03-08 |
EP1117836A2 (en) | 2001-07-25 |
JP2002531061A (en) | 2002-09-24 |
WO2000018961A2 (en) | 2000-04-06 |
CA2344550A1 (en) | 2000-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL155952A0 (en) | Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
GB9925804D0 (en) | Biological materials and method useful in the diagnosis and treatment of diseases | |
AU2002318112B2 (en) | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers | |
AU6035299A (en) | Interstitial fluid methods and devices for determination of an analyte in the body | |
AU8571598A (en) | Cancer associated nucleic acids and polypeptides | |
AU3560399A (en) | Tumor associated nucleic acids and uses therefor | |
AU6502199A (en) | Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
AU9312198A (en) | Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer | |
AU3510200A (en) | Human dickkopf-related protein and nucleic acid molecules and uses therefor | |
GB9617616D0 (en) | Assaying protein fragments in body fluids | |
IL155951A0 (en) | Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
AU2001285018A1 (en) | Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer | |
MXPA03004577A (en) | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer. | |
IL155954A0 (en) | Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
AU6653698A (en) | Use of the p-ten suppressor gene in diagnosis and treatment of cancer | |
AU6278099A (en) | Biological reagents and methods for determining the mechanism in the generation of beta-amyloid peptide | |
AU4328399A (en) | Nucleic acid-cobalamin complexes and their use in gene therapy | |
AU2001286541A1 (en) | Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer | |
GB9828564D0 (en) | Materials and methods for the treatment and diagnosis of cancer | |
AU1464399A (en) | Reagent for tumor therapy and/or imaging | |
ZA200301143B (en) | Biological materials and methods useful in the diagnosis and treatment of diseases. | |
GB0205963D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB0113011D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB9917491D0 (en) | Biological materials and methods useful in the diagnosis and treastment of diseases | |
IL142311A0 (en) | Methods and compositions for the diagnosis and therapy of prostate cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |